EUVIMED · CrossrefJournal
CPT: Pharmacometrics & Systems Pharmacology
ISSN 2163-8306 · Wiley
Latest articles
Issue Information
Pharmacokinetics and Initial Bolus Dosing of Furosemide in Children on ECMO
Physiologically Based Pharmacokinetic Modeling of Fruquintinib and Its Metabolite to Assess Drug–Drug Interaction Liability as an Object or Precipitant
Drug–Drug Interactions of Cenobamate With Medications: Dose‐Dependent Induction/Inhibition and Clinical Implications
Assessment of Allometric Scaling Methods for the Prediction of Human Pharmacokinetic of LNA ‐i‐ miR ‐221
Reframing QSP : AI ‐Driven Multi‐Modal Data as a New Measurement Layer
Comparing the Effectiveness of a Longitudinal Model With Logistic Regression for Binary Endpoints to Support Better Clinical Decision Making
Model‐Informed First‐In‐Human Dose Selection for AZD2796 , a High‐Affinity Anti‐ LILRB2 Antibody
A PK ‐Driven Quantitative Systems Pharmacology Model Predicts Cytokine Release Syndrome Severity Across T Cell‐Activating Therapies via a Locked Cytokine Amplification Network
Application of Physiologically Based Pharmacokinetic Modeling to Optimize Assessment of Age‐Related Fluoxetine Accumulation in the Elderly
Issue Information
Development of a Disease‐Specific Virtual Malaria Population for Physiologically‐Based Pharmacokinetic Modeling
A Physiologically Based Pharmacokinetic Model to Predict Potential Drug–Drug Interactions of TPN171 , a Novel Phosphodiesterase Type 5 Inhibitor
Using Stochastic Simulation‐Estimation and Automated Model Development to Assess Power and Accuracy for Covariate Identification
DDIapp —A Web‐Based Application for Static Drug–Drug Interaction Assessment
Application of Population‐Based Meta‐Heuristic Algorithms for Robust Initialization in Mechanistic Pharmacometric Modeling
Physiologically Based Pharmacokinetic Model of Brigatinib in Healthy Volunteers and Patients With Cancer
Extrapolating Vincristine‐Induced Peripheral Neuropathy From Caucasian to Kenyan Populations: Impact of Type I and Type II Selection Bias
Refinement of Operating Characteristics for Model‐Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology
Reliable Apparent Permeability Prediction Through Benchmarking, Stability, Uncertainty Quantification, and Explainable Machine Learning
Structured Schemas for Provenance‐Rich, LLM ‐Assisted QSP Model Calibration
Bayesian Workflow for Minimal PBPK Models: Case Study of Dapagliflozin
Utilizing Virtual Clinical Trials to Inform Target Coverage That Drives RSV Antiviral Efficacy
Post‐Marketing Requirements for Anticancer Drugs Approved in Japan, 2001–2024: A Cross‐Sectional Analysis
Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials
Correction to “Development of an Agent‐Based Model to Investigate Durability of Factor IX Activity in Hemophilia B Patients Treated With Etranacogene Dezaparvovec”
Beyond Traditional Covariates: An Interpretable Machine Learning Workflow for Improved Hybrid Pharmacometric Modeling
Machine Learning Enables Rapid Prediction of Acid‐Reducing Agent Drug Interactions: A Streamlined Complement to PBPK Modeling
Context Engineering for AI ‐Assisted Pharmacometrics: A Practical Tutorial
A Systematic Review of Published Physiologically Based Pharmacokinetic Models for Drug Excretion Into Human Breastmilk: Knowledge Gaps and Opportunities to Optimize Reporting and Modeling Practices
EUVIMED